Clinical Trial Update: Open-Label Safety and PK Study of ER Hydromorphone Tablets in Opioid-Tolerant Pediatric Chronic Pain Patients [Phase 3]

View source ↗

Summary

Open-label safety and pharmacokinetics study of extended-release hydromorphone tablets in opioid-tolerant pediatric chronic pain patients was terminated; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• ER Hydromorphone Tablets (hydromorphone)

Snippet

Sponsor: Mallinckrodt | Conditions: Chronic Pain | Phase 3 | Status: TERMINATED | Results posted: 2020-05-20